Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East

Japanese Journal of Clinical Oncology

Volumn 29, Issue 1, 1999, Pages 11-15

  Imoto, Shigeru ^a   Hasebe, Takahiro ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Breast cancer; Indigocarmine; Lymphatic mapping; Sentinel lymph node; Sentinel node biopsy

Indexed keywords

INDIGO CARMINE;

ADULT; AGED; ARTICLE; AXILLA; BIOPSY; BREAST TUMOR; CANCER CENTER; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MASTECTOMY; MIDDLE AGED; PATHOLOGY; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST NEOPLASMS; CANCER CARE FACILITIES; FEASIBILITY STUDIES; FEMALE; HUMANS; INDIGOTINDISULFONATE SODIUM; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED;

EID: 0032602799     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.1.11     Document Type: Article

References (26)

1. Haagensen CD. The history of the surgical treatment of breast carcinoma from 1863 to 1921. In: Haagensen CD, editor. Diseases of the Breast. Philadelphia: Saunders 1986;864-71.
2. Japanese Breast Cancer Society. Results of questionnaires concerning breast cancer surgery in Japan: an update in 1998. Breast Cancer 1998;5:209.
3. Petrek JA, Lemer R. Lymphedema. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the Breast. Philadelphia: Lippincott-Raven 1996, 896-903.
4. Haagensen CD. The natural history of breast carcinoma. In: Haagensen CD, editor. Diseases of the Breast. Philadelphia: Saunders 1986;653-5.
5. Chadha M, Chabon AB, Freidmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1994;73:350-3.
6. Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994;86:1771-5.
7. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 1997;79:1918-22.
8. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44.
9. Haffty BG, Ward B, Pathare P, Salem R, Makhann C, Beinfield M, et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 1997;15:691-70.
10. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
11. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
12. Wells KE, Rapaport DP, Cruse CW, Payne W, Albertini J, Berman C, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg 1997;100:591-4.
13. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-9.
14. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
15. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. J Am Med Assoc 1996;276:1818-22.
16. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
17. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
18. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
19. Galimberti V, Zurrida S, Zucali P, Luini A. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 1998;7:8-10.
20. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-53.
21. O'Hea BJ, Hill ADK, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:432-7.
22. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
23. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Watanabe S, et al. Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast carcinoma. Cancer 1989;65:1794-1800.
24. Harris JR, Morrow M. Local management of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the Breast. Philadelphia: Lippincott-Raven 1996, 509-10.
25. Tuner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast cancer. Ann Surg 1997;226:271-8.
26. Miner T, Shriver C, Flicek P, Maniscalco-Theberge M, Jaques D, Krag D. Additional guidelines for the safe management of radiation associated with sentinel lymph node biopsy. Presented at the 51st Annual Cancer Symposium (SSO) and 1st World Congress of Surgical Oncology (WFSOS) 1998 (Abstract No. 27).